Toxicity of the high-dose chemotherapy CTC regimen (cyclophosphamide, thiotepa, carboplatin): the Netherlands Cancer Institute experience

द्वारा Schrama, J G, Holtkamp, M J, Baars, J W, Schornagel, J H, Rodenhuis, S
प्रकाशित 2003

Evaluating the quality of life of cancer patients: assessments by patients, significant others, physicians and nurses

द्वारा Sneeuw, K C A, Aaronson, N K, Sprangers, M A G, Detmar, S B, Wever, L D V, Schornagel, J H
प्रकाशित 1999

Efficacy of up-front 5-fluorouracil-epidoxorubicin-cyclophosphamide (FEC) chemotherapy with an increased dose of epidoxorubicin in high-risk breast cancer patients.

द्वारा van der Wall, E., Rutgers, E. J., Holtkamp, M. J., Baars, J. W., Schornagel, J. H., Peterse, J. L., Beijnen, J. H., Rodenhuis, S.
प्रकाशित 1996

Determinants of the elimination of methotrexate and 7-hydroxy-methotrexate following high-dose infusional therapy to cancer patients

द्वारा Joerger, M, Huitema, A D R, van den Bongard, H J G D, Baas, P, Schornagel, J H, Schellens, J H M, Beijnen, J H
प्रकाशित 2006

Phase II and pharmacological study of oral paclitaxel (Paxoral) plus ciclosporin in anthracycline-pretreated metastatic breast cancer

द्वारा Helgason, H H, Kruijtzer, C M F, Huitema, A D R, Marcus, S G, ten Bokkel Huinink, W W, Schot, M E, Schornagel, J H, Beijnen, J H, Schellens, J H M
प्रकाशित 2006